Thursday, June 13, 2013

Bravo, Supreme Court!

A HUGE BRAVO to the Supreme Court for unanimously ruling that the Myriad Genetics' patents on the BRCA-1 and BRCA-2 genes are invalid. This will open the doors for more competition in testing for the cancer-related genetic mutations, which should in turn lower the costs for these tests, and make them more widely available for those who choose to be tested.


  1. Did you know that there's new research on the the brca gene for pancreatic and biliary duct cancers, too? And that's it's more common in Ashkenazi women?

    1. i knew about the Askenazi link (being of Ashkenazi descent myself), but not about the link to pancreatic and biliary duct cancers...this gene mutation is nasty!